Acupuncture and integrative medicine for improving quality of life during wartime
Impact of Acupuncture and Integrative Medicine on Patients&Amp;Amp;#39; Quality-of-life During National Emergency and Wartime in Integrative Oncology and Inpatient Settings
This study is testing whether acupuncture and integrative medicine can help improve the quality of life for people affected by the military conflict in Israel, including those undergoing cancer treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Carmel Medical Center Academic / other |
| Locations | 1 site (Haifa, Israel) |
| Trial ID | NCT06604455 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of acupuncture and integrative medicine on the quality of life of patients affected by the ongoing military conflict in Israel. It involves a diverse population, including those undergoing oncology treatment, and offers treatments over three weeks to address war-related physical and emotional distress. Participants will be randomly assigned to receive either acupressure-relaxation alone or in combination with acupuncture, with assessments of their quality of life conducted at multiple time points. The study aims to provide insights into the effectiveness of these interventions in a unique and challenging setting.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older who are hospitalized or receiving outpatient oncology treatment and have quality of life concerns related to the war.
Not a fit: Patients who are unable to read and provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly enhance the quality of life for patients affected by war-related stressors.
How similar studies have performed: While integrative medicine approaches have been explored in various contexts, this specific application during wartime is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with cancer, age ≥ 18 years who are either hospitalized or undergoing oncology treatment in an outpatient care setting; or hospitalized for any other diagnosis * Patients expressing quality of life related concerns affected directly or indirectly to the war and related security status. Exclusion Criteria: Inability to read and provide informed consent
Where this trial is running
Haifa, Israel
- Carmel Medical center — Haifa, Israel, Israel (Recruiting)
Study contacts
- Principal investigator: Eran Ben-Arye, MD — Director, Integrative Oncology Program
- Study coordinator: Eran Ben-Arye, MD
- Email: ERANBE@clalit.org.il
- Phone: +972528709282
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.